Features July 2014 Issue

AFib Patients Face Higher Risks with Antiplatelet Therapy

You may be at a higher risk for bleeding if you add antiplatelet drugs to anticoagulant therapy.

Atrial fibrillation (AFib) is usually treated with anticoagulant medications such as warfarin (Coumadin). AFib is the uncoordinated beating of the heartís upper chambers (atria), which allows blood to pool in the heart. The result can be a blood clot that could leave the heart and eventually cause a stroke.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.